dc.creator | Matos M.J. | |
dc.creator | Herrera Ibatá D.M. | |
dc.creator | Uriarte E. | |
dc.creator | Viña D. | |
dc.date.accessioned | 2020-09-02T22:23:01Z | |
dc.date.accessioned | 2022-11-08T20:21:37Z | |
dc.date.available | 2020-09-02T22:23:01Z | |
dc.date.available | 2022-11-08T20:21:37Z | |
dc.date.created | 2020-09-02T22:23:01Z | |
dc.date.issued | 2020 | |
dc.identifier | 15, 6, 532-538 | |
dc.identifier | 18607179 | |
dc.identifier | https://hdl.handle.net/20.500.12728/5337 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144099 | |
dc.language | en | |
dc.publisher | John Wiley and Sons Ltd | |
dc.subject | Antioxidants | |
dc.subject | Coumarin-rasagiline hybrids | |
dc.subject | hMAO-B inhibitors | |
dc.subject | Neuroprotectors | |
dc.subject | Parkinson's disease | |
dc.subject | 4 (but 2 yn 1 ylamino)coumarin | |
dc.subject | amine oxidase (flavin containing) isoenzyme B | |
dc.subject | antioxidant | |
dc.subject | coumarin | |
dc.subject | monoamine oxidase inhibitor | |
dc.subject | neuroprotective agent | |
dc.subject | rasagiline | |
dc.subject | unclassified drug | |
dc.subject | animal experiment | |
dc.subject | antioxidant activity | |
dc.subject | Article | |
dc.subject | DPPH radical scavenging assay | |
dc.subject | embryo | |
dc.subject | enzyme inhibition | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | rat | |
dc.title | Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents | |
dc.type | Article | |